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The host response to intracellular pathogens requires the coordinated action of both the innate and acquired immune
systems. Chemokines play a critical role in the trafficking of immune cells and transitioning an innate immune
response into an acquired response. We analyzed the host response of mice deficient in the chemokine receptor CCR5
following infection with the intracellular protozoan parasite Toxoplasma gondii. We found that CCR5 controls
recruitment of natural killer (NK) cells into infected tissues. Without this influx of NK cells, tissues from CCR5-deficient
(CCR5
 / ) mice were less able to generate an inflammatory response, had decreased chemokine and interferon c
production, and had higher parasite burden. As a result, CCR5
 / mice were more susceptible to infection with T. gondii
but were less susceptible to the immune-mediated tissue injury seen in certain inbred strains. Adoptive transfer of
CCR5
þ/þ NK cells into CCR5
 /  mice restored their ability to survive lethal T. gondii infection and demonstrated that
CCR5 is required for NK cell homing into infected liver and spleen. This study establishes CCR5 as a critical receptor
guiding NK cell trafficking in host defense.
Citation: Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, et al. (2006) CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS
Pathog 2(6): e49. DOI: 10.1371/journal.ppat.0020049
Introduction
A protective host response to intracellular pathogens, such
as viruses and certain bacteria and protozoan parasites,
requires a coordinated innate and acquired immune re-
sponse. Toxoplasma gondii, an intracellular protozoan parasite
of signiﬁcant clinical importance, evokes a similar host
response in mice and humans and therefore represents an
excellent model system with which to use mouse genetics to
dissect components of an effective immune response [1].
The innate immune response to T. gondii consists of
neutrophil [2,3] and natural killer (NK) cell responses, while
the acquired immune response requires interferon c (IFNc)-
producing CD4 and CD8 T cells [4,5]. The critical role for NK
cells in the innate response to T. gondii has been documented
in interleukin (IL)-12 treated SCID mice [6] and in b2
microglobulin-deﬁcient mice [7]. Early NK cell function is
essential for host survival because it is an early source of IFNc
production [8].
To perform this essential role in innate host defenses, NK
cells must trafﬁc to the site of infection where they release
IFNc, which is critical for macrophage activation and
increased expression of major histocompatibility complex
class II [9,10]. NK cells are generated in the bone marrow, and
after leaving this compartment are found in peripheral
blood, spleen, and liver. They can, however, be induced to
localize in tissues in response to infectious and inﬂammatory
stimuli. The molecular mechanisms controlling NK cell
trafﬁcking are just beginning to be identiﬁed. Like other
leukocytes, chemokines are thought to play an important role
in NK cell trafﬁcking. NK cells have been reported to express
multiple chemokine receptors, including CXCR1–CXCR4,
CCR4, CCR5, CCR7, CCR8 and CX3CR1; however, their
individual roles in NK cell homing in vivo have not been
delineated [11–14]. The chemokine CCL3/MIP-1a has been
shown to be essential for early NK cell migration into the
liver in response to mouse cytomegalovirus infection [15],
although the NK cell receptor that mediates this important
function of MIP-1a has not been elucidated. These NK cells
are an important source of the IFNc needed for the induction
of chemokines, such as CXCL10/IP-10 and CXCL9/MIG, that
control the trafﬁcking of activated T cells into infected tissues
[16]. Thus, chemokines are an important link between the
innate and adaptive immune response operating at the level
of NK cell recruitment into tissues and subsequent con-
version of the NK cell response into a T cell response through
the activity of IFNc-inducible chemokines.
The chemokines and chemokine receptors responsible for
NK cell trafﬁcking in response to T. gondii infection have not
Editor: John Boothroyd, Stanford University, United States of America
Received May 27, 2005; Accepted April 12, 2006; Published June 9, 2006
DOI: 10.1371/journal.ppat.0020049
Copyright:  2006 Khan et al. This is an open-access article distributed under the
terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author
and source are credited.
Abbreviations: IFNc, interferon c; IL, interleukin; NK, natural killer; PI, postinfection;
QPCR, quantitative PCR
* To whom correspondence should be addressed. E-mail: ikhan@lsuhsc.edu (IAK);
luster.andrew@mgh.harvard.edu (ADL)
[ These authors contributed equally to this work.
PLoS Pathogens | www.plospathogens.org June 2006 | Volume 2 | Issue 6 | e49 0484been studied. However, as for the mouse cytomegalovirus
model, we have found that IFNc-inducible chemokines play
a critical role in T cell trafﬁcking into infected tissues in T.
gondii infection [17]. We speculated that chemokines, and in
particular CCL3/MIP-1a and its receptors CCR1 and CCR5,
may act upstream of IFNc, controlling the recruitment of
NK cells into T. gondii-infected tissues. Recently, we
evaluated CCR1-deﬁcient mice and found a normal NK cell
response in the tissues of the infected animals [3]. In the
present study, we found that CCR5-deﬁcient mice have an
impaired ability to recruit NK cells into infected tissues,
which leads to a diminished cytokine and chemokine
response, higher tissue parasite burdens, and alterations in
susceptibility to T. gondii infection dependent on genetic
background.
Results
CCR5
 /  Mice in the C57BL/6 Background Survive Longer
than Wild-Type Mice
Previous studies by us and others have demonstrated that
peroral infection of C57BL/6 mice with T. gondii cysts result in
their death due to a cytokine-mediated hyperinﬂammatory
response [18–20]. To determine the susceptibility of CCR5
 / 
mice to T. gondii infection, CCR5
 /  and CCR5
þ/þ mice in the
C57BL/6 background were infected perorally with 20, 50, and
100 cysts of T. gondii. All CCR5
þ/þmice infected with 50 or 100
cysts died by day 8–10 postinfection (PI) (Figure 1A). In
contrast, CCR5
 /  mice infected with the similar parasite
doses did not die until day 18 PI (Figure 1A). When the
infective dose was lowered to 20 cysts, about 30% of wild-type
mice died (ﬁve of 18 mice from three separate experiments),
while none of the CCR5
 / mice succumbed to the infection at
this dose. In addition, the number of T. gondii cysts in the
brains of the survivors was enumerated after 1 mo PI, and
CCR5
 /  mice had a 5-fold higher cyst number (2,563 6 350)
than control wild-type mice (538 6 155) (p ¼ 0.002)
(unpublished data).
CCR5
 / Mice in the C57BL/6 Background Have a Reduced
Hyperinflammatory Response
To determine whether the increased survival of CCR5
 / 
mice in the C57BL/6 background was due to a diminished
inﬂammatory response in these animals, tissues (liver and
ileum of small bowel) from the CCR5
 /  and CCR5
þ/þ mice
were histopathologically analyzed at day 7 PI. Inspection of
multiple histological sections showed reproducible morpho-
logical changes. As expected, the liver of the wild-type mice
had extensive fatty degeneration of hepatocytes, as has been
previously described in the hyperimmune response in these
mice [19]. Multiple mixed lymphocytic and granulocytic
inﬂammatory nodules of 50–100 lm diameter were scattered
throughout the parenchyma. Intracellular T. gondii were not
observed, which is typical in this stage of the infection (Figure
1B). In contrast, CCR5
 /  mice showed normal hepatocyte
morphology and small, scattered inﬂammatory nodules
throughout the hepatic parenchyma, made up largely of
lymphocytes (Figure 1B). Sections of the small bowel showed
patchy, superﬁcial necrosis and hemorrhage in the wild-type
mice (Figure 1B), and normal bowel morphology in the
CCR5
 /  mice (Figure 1B).
Early Parasite Load Is Similar in CCR5
 /  and CCR5
þ/þ Mice
on the C57BL/6 Background
T. gondii infection of the tissues of C57BL/6 mice has been
reported to induce a hyperinﬂammatory response that leads
to early death [19,20]. In the present studies we found that
CCR5
 /  mice on this genetic background had a reduced T.
gondii-mediated inﬂammatory reaction, which enabled them
to survive the initial period. To further conﬁrm that the
death of the wild-type C57BL/6 mice was not due to increased
parasite multiplication, tissues from both wild-type and
CCR5
 /  C57BL/6 mice were analyzed for parasite load
(Figure 1C). The assay was performed at day 7 PI, just before
wild-type C57BL/6 mice began to die. With the exception of
the liver, no difference in the parasite number was seen
between the tissues of the C57BL/6 wild-type and CCR5
 / 
mice, conﬁrming the histopathological ﬁndings that the
increase in mortality observed in CCR5
þ/þ mice was the result
of the T. gondii-induced hyperimmune response, not of a
difference in parasite burden. However, CCR5
 /  mice in the
C57BL/6 challenged with 50 or 100 cysts ultimately suc-
cumbed to the infection at about day 18–19 PI. In contrast to
the early hyperimmune death seen in wild-type C57BL/6
mice, CCR5
 /  C57BL/6 mice apparently died from an
increased parasite burden, as these mice exhibited a 10- to
100-fold increase in tissue (liver, lung, and spleen) parasite
load at day 17 PI compared to day 7 PI. Moreover,
histopathological analysis of these mice at this time point
indicated high parasite multiplication with intracellular
parasites readily identiﬁed in the liver (unpublished data).
CCR5
 /  Mice on a Mixed C57BL/6x129 Background Are
Susceptible to T. gondii Infection
To further establish that CCR5
 /  mice have an impaired
host response to T. gondii, we studied the response of CCR5
 / 
mice in the C57BL/6x129 background. Based on our prior
experience, mice on this genetic background do not die from
T. gondii infection, even at an infective dose of over 100 cysts
of the 76 K strain. Mice on this mixed genetic background
also do not exhibit a parasite-induced hyperimmune
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Synopsis
Toxoplasma gondii, an obligate intracellular parasite, evokes a strong
cellular immune response, which is critical for host protection.
Chemokines and their receptors control the trafficking of immune
cells to sites of infection. In this study, the authors examined the
immune response to T. gondii in mice deficient in the chemokine
receptor CCR5. CCR5-deficient mice exhibited a decreased inflam-
matory response, which led to a higher parasite burden and
ultimate mortality. The deficiency in the immune response in CCR5-
deficient mice was the result of decreased migration of natural killer
(NK) cells into infected tissues. Transfer of normal NK cells into CCR5-
deficient mice restored NK cell homing into infected tissue and the
normal immune response capable of controlling T. gondii infection.
These findings demonstrate an important role for CCR5 in trafficking
the NK cells during acute T. gondii infection. Furthermore, since
CCR5 is the main co-receptor for HIV-1 entry into cells, the results of
this study raise a concern about the potential complication of
impaired NK cell function in the clinical use of CCR5 antagonists,
currently being developed as therapeutics for HIV-1 and inflamma-
tory diseases. This may be of particular concern for HIV-1-infected
patients coinfected with T. gondii or for those who acquire an acute
T. gondii infection while taking a CCR5 antagonist.response. CCR5
 /  mice on the C57BL/6x129 background and
wild-type control littermates were challenged with different
doses of T. gondii cysts as described above. As expected, none
of the wild-type mice succumbed to infection following
infection with 20, 50, or even 100 cysts (Figure 2A). In
contrast, all of the CCR5
 /  mice challenged with either 50 or
100 cysts died between days 17 and 21 PI (Figure 2A). None of
the wild-type or CCR5
 /  mice died when challenged with a
dose of 20 cysts.
CCR5
 / Mice Have a Higher Parasite Burden in the Tissues
Liver and ileum of small bowel from CCR5
 / and wild-type
littermate control mice were histopathologically analyzed at
day 14 PI. Tissues from CCR5
 /  mice demonstrated severe
injury, suggestive of uncontrolled parasite replication (Figure
2B). The intestinal lesions of CCR5
 /  mice were also
characterized by a polymorphonuclear granulocyte-rich
inﬂammatory inﬁltrate, demonstrating continued acute
infection, which differs from the inﬁltrate seen in the
littermate wild-type controls (Figure 2B). The lesions in the
ileum of CCR5
 / mice indicated high parasite multiplication,
and intracellular parasites were readily identiﬁed (Figure 2B).
Conversely, both tissues from wild-type mice exhibited only
moderate inﬂammatory reaction, typical of mice that are
recovering from acute infection.
To further conﬁrm the observation that the absence of
CCR5 compromised the ability of mice to inhibit parasite
multiplication, tissues from CCR5
 /  and CCR5
þ/þ mice on a
C57BL/6 x129 background were assayed for parasite burden
at days 7 and 15 PI. Interestingly, unlike C57BL/6 CCR5
 / 
mice (Figure 1C), CCR5
 /  mice in the C57BL/6 x129 at day 7
exhibited an increased parasite load (;10-fold more parasite
DNA) in the liver, lung, and small intestine (unpublished
data). The parasite load in CCR5
 /  mice, in comparison to
wild-type littermate mice, was further elevated at day 15 PI in
all tissues examined (Figure 2C), demonstrating that CCR5
was required for effective parasite control.
Impaired NK Cell Response in CCR5
 /  Mice
We sought to determine whether the reduced inﬂammatory
response in the CCR5
 /  mice was due to the inability of the
immune cells to trafﬁc into infected sites. Spleens and livers
of CCR5
 /  and CCR5
þ/þ mice on the C57BL/6 background
were isolated at day 7 PI. Single-cell preparations of
splenocytes and hepatic lymphocytes were stained with
labeled antibodies against leukocyte markers and analyzed
by FACS. Wild-type mice on both C57BL/6 and C57BL/6x129
backgrounds showed the expected inﬂux in total T cell
(CD3
þ) and CD4
þ and CD8
þ T cell subset populations in
response to T. gondii infection in the spleen (Figure 3A and
3C) and liver (Figure 3B and 3D). CCR5
 /  mice in both the
C57BL/6 and C57BL/6 x129 backgrounds also had a com-
parable increase in CD3
þ, CD4
þ, and CD8
þ T cells in infected
tissue. To determine whether lack of CCR5 had an effect on
Figure 1. Survival, Histopathology, and Parasite Load of CCR5
 /  and
CCR5
þ/þMice in a C57BL/6 Background following Infection with Different
Doses of T. gondii
(A) Survival. Female CCR5
 / mice (5–7 wk old) and age-matched CCR5
þ/þ
wild-type controls in the C57BL/6 background were challenged perorally
with the cysts of the 76K strain of T. gondii. The animals were monitored
for survival on a daily basis. There were six animals per group and the
experiment was performed three times with similar results.
(B) Histopathology. Photomicrographs of hematoxylin and eosin-stained
liverandileumof small bowelisolatedfrominfectedCCR5
 / andCCR5
þ/þ
mice. Liver of infected CCR5
þ/þ mouse reveals hepatocytes with
extensive fatty degeneration. A nodule of inflammatory cells is seen in
the center of the field, composed of lymphocytes and granulocytes.
Hepatocyte morphology is preserved in liver of an infected CCR5
 / 
mouse. A small nodule of inflammatory cells, largely composed of
lymphocytes, is seen in the center of the field. Ileum of an infected
CCR5
þ/þ mouse contains extensive epithelial necrosis and ulceration.
Dilated blood vessels with hemorrhage are evident. The epithelial
architecture is preserved in ileum of infected CCR5
 / mouse. Bars: ileum,
100 lm; liver, 50 lm.
(C) Level of parasite DNA. Groups of CCR5
 /  and CCR5
þ/þ mice on the
C57BL/6 background were infected perorally with 20 cysts of T. gondii.A t
day 7 PI, small intestine, liver, spleen, lung, and brain from both CCR5
 / 
and wild-type mice (three mice per group) were collected and the level
of parasite load in the tissues was determined by competitive DNA PCR.
The experiment was performed twice with similar results.
DOI: 10.1371/journal.ppat.0020049.g001
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CCR5 Mediates NK Homing in Infectionthe generation of antigen-speciﬁc immune responses against
T. gondii, antigen-speciﬁc proliferative responses were meas-
ured using fractionated CD4
þ and CD8
þ splenocytes from
C57BL/6 x129 wild-type and CCR5
 /  mice. No signiﬁcant
differences in antigen-speciﬁc proliferation of CD4
þ or CD8
þ
T cells in the two strains of mice were observed (Figure 4A
and 4B). In a separate study, supernatants from CD4
þ and
CD8
þ T cell cultures were collected 72 h after antigenic
stimulation, and levels of IFNc determined by ELISA. Similar
to proliferation studies, CD4
þ and CD8
þ T cells from both
CCR5
 /  and wild-type mice secreted equivalent amounts of
IFNc in response to antigenic stimulation (Figure 4C and 4D).
Furthermore, wild-type and CCR5
 /  had a comparable
increase in the number of IFNc-producing CD4
þ and CD8
þ
T cells found in the spleen 7 d after T. gondii infection as
determined by intracytoplasmic cytokine staining (Figure 4E).
These data indicate that CCR5 deﬁciency did not have a
signiﬁcant impact on the generation of an antigen-speciﬁc T
cell response against the parasite.
Although no differences in T cell immunity was observed
between wild-type and CCR5
 /  mice, a deﬁcient NK cell
response to T. gondii was apparent in the CCR5
 /  mice.
Infected wild-type C57BL/6 and C57BL/6x129 mice exhibited
a 3.5- to 8-fold increase in the NK cell population in the
spleen and liver, respectively, as compared to uninfected
animals on day 7 PI. In contrast, however, CCR5
 /  mice on
both the C57BL/6 and C57BL/6x129 backgrounds did not
have this increase in NK cell numbers in the spleen (Figure
3A and 3C) and liver (Figure 3B and 3D) in response to T.
gondii infection. These data reveal a critical role for CCR5 in
NK cell trafﬁcking into the liver and spleen in vivo.
Since the NK1.1 marker is also found on NK T cells in
addition to true NK cells, we determined whether the
increase in the NK cell population seen during T. gondii
infection was restricted to classical NK cells (CD3
 )o r
included NK T cells (CD3
þ). Spleen, liver, lymph nodes, and
blood from infected wild-type and CCR5
 /  mice were
analyzed for NK1.1
þCD3
þ and NK1.1
þCD3
  cells on day 7
PI. In agreement with our above-described ﬁndings, we
detected a 4- to 7-fold increase in NK1.1
þCD3
  cells in the
spleen and liver of wild-type mice of both strains at day 7
following infection with T. gondii (Figure 5A, 5B, 5E, and 5F).
In contrast, infected CCR5
 / mice had essentially no increase
in numbers of NK1.1
þCD3
  cells in the spleen and liver.
Interestingly, however, infected CCR5
 /  mice in both strains
had 4-fold more NK1.1
þCD3
  cells in the blood (Figure 5C, p
¼ 1.9 3 10
 5; Figure 5G, p ¼ 0.025) and mesenteric lymph
nodes compared to infected wild-type mice (Figure 5D, p ,
4.4 3 10
 7). These observations suggest that CCR5
 /  mice
generated and mobilized an NK cell response to T. gondii, but
were unable to recruit these cells into tissue sites of infection.
There was also a statistically signiﬁcant 3- to 5-fold increase
in NK1.1
þCD3
þ cells in the spleen, liver, and lymph nodes
following infection in mice with C57BL/6 background.
Similar to what was observed for NK1.1
þCD3
  cells in
Figure 2. Survival, Histopathology, and Parasite Load of CCR5
 /  and
CCR5
þ/þ Mice in a C57BL/6x129 Background following Infection with
Different Doses of T. gondii
(A) Survival. Female CCR5
 / mice (5–8 wk old) and age-matched CCR5
 / 
wild-type littermate controls, both in a C57BL/6x129 background, were
challenged perorally with the cysts of the 76K strain of T. gondii. The
animals were monitored for survival on daily basis. There were six
animals per group and the experiment was performed three times with
similar results. All CCR5
þ/þ mice survived at the three doses of cysts
tested.
(B) Histopathology. Photomicrographs of hematoxylin and eosin-stained
liver and ileum of small intestine isolated from infected CCR5
þ/þmice and
CCR5
 / miceatday14PI.Wild-typeliver:Moderatefattychangeisseenin
hepatocytes, with small foci of mixed polymorphonuclear and mono-
nuclearinfiltration.Bar,10lm.CCR5
 / liver:Severefattychangesareseen
in hepatocytes with mononuclear and polymorphonuclear inflammatory
nodules. Bar, 10 lm. Wild-type small intestine: The superficial mucosa is
missing in some places (arrow) and no parasite multiplication is evident.
Bar, 100 lm. CCR5
 /  small intestine. The superficial mucosa is largely
missingandamixedinflammatory infiltrateincludingpolymorphonuclear
cells is evident within the lamina propria and superficial mucosa. Bar, 100
lm. Inset: Higher magnification with arrow pointing to tachyzoites in
lamina propria of CCR5
 /  mice. Bar, 75 lm.
(C) Level of parasite DNA. Groups of CCR5
 /  mice and wild-type
littermate controls both on a C57BL/6x129 background were infected
perorally with 20 cysts of T. gondii. At day 14 PI, small intestine, liver,
spleen, lung, and brain from both CCR5 /  and wild-type mice (three
mice per group) were collected and the parasite load in the tissues was
determined by competitive PCR. The experiment was performed twice
with similar results.
DOI: 10.1371/journal.ppat.0020049.g002
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 /  mice, NK1.1
þCD3
þ cells were found in higher
numbers in the blood and mesenteric lymph nodes and in
lower numbers in the spleen and liver. However, in C57BL/
6x129 mice, a signiﬁcant increase in the NK1.1
þCD3
þ cells in
response to T. gondii infection was observed only in the liver
of wild-type mice (Figure 5F). These observations suggest that
CCR5
 / mice generated and mobilized an NK T cell response
to T. gondii, but were unable to recruit these cells into tissue
sites of infection.
Early Burst of CCR5 Ligands in Infected Tissue
We examined the expression of the three known CCR5
ligands, MIP-1a/CCL3, MIP-1b/CCL4, and RANTES/CCL5, in
infected wild-type and CCR5
 /  C57BL/6 mice on days 3, 5,
and 7 post T. gondii infection. Mice were sacriﬁced at days 0, 3,
5 and 7 PI and tissues (spleen, lung, liver, and small intestine)
were assayed for chemokine mRNA by quantitative PCR
(QPCR) (Figure 6). We detected a similar increase in CCL3
and CCL4 mRNA levels in the spleen, lung, and liver on day 5
PI in both wild-type and CCR5
 /  mice. CCL5 was similarly
increased in lung and liver on day 5 in both wild-type and
CCR5
 /  mice. Interestingly, levels of CCL3 continued to rise
on day 7 in spleen and liver of wild-type, but not of CCR5
 / 
mice, leading to differences in the levels of CCL3 on day 7 in
the spleen and liver, at which time we found differences in
NK cell numbers in those tissues. CCL5 also had a similar
increase in infected wild-type and CCR5
 /  mice in the lung
and liver on day 5. However, by day 7 the levels in CCR5
 / 
mice decreased, while the levels in the wild-type did not.
Thus, we found that an early burst of CCR5 ligand production
occurred in both wild-type and CCR5
 /  mice following
infection that likely accounted for the recruitment of CCR5
þ
NK cells into these tissues by day 7. However, without this
inﬂux of NK cells in the CCR5
 / mice, the expression of these
ligands decreased by day 7, suggesting that a positive
feedback loop exists between NK cells and the production
of CCR5 ligands that lead to NK cell recruitment. It is also
worth noting that we detected very low levels of CCL3 and
CCL4 in the small intestine, which might explain our inability
to detect NK cell recruitment into this tissue following T.
gondii infection. CCL3 and CCL4 are induced in many cell
types in response to proinﬂammatory stimuli, such as
lipopolysaccharide and tumor necrosis factor a. Decreased
levels of CCL3 and CCL4 in infected CCR5
 /  mice at day 7
thus likely reﬂects a diminished inﬂammatory response in
CCR5
 / mice. CCL5 is also induced by multiple inﬂammatory
stimuli and is also constitutively expressed in T cells. Thus,
decreased CCL5 levels in CCR5
 /  mice on day 7 likely also
reﬂects a decreased inﬂammatory response in the CCR5
 / 
mice.
Diminished IFNc and IFNc-Inducible CXCR3 Chemokine
Ligands in CCR5
 /  Mice at Day 7 PI
As NK cells are an important source of IFNc during early T.
gondii infection [8], we analyzed the mRNA expression of
IFNc, and the IFNc-inducible CXCR3 chemokine ligands IP-
10/CXCL10, MIG/CXCL9 and I-TAC/CXCL11 in wild-type
and CCR5
 /  mice. Mice were sacriﬁced at day 0, 3, 5 and 7 PI
and tissues (spleen, lung, liver, and small intestine) were
assayed for chemokine mRNA by QPCR (Figure 6). As others
and we have described previously, IFNc, CXCL10, and CXCL9
were signiﬁcantly induced in all organs tested following
infection. CXCL11 was also induced in the spleen, lung, and
liver. In all cases, induction of these cytokines was similar in
wild-type and CCR5
 / mice up to day 5. However, as was seen
above for the CCR5 ligands, by day 7 the levels of IFNc and
IFNc-inducible chemokines markedly diminished in organs
harvested from infected CCR5
 /  mice. Thus, a reduction of
Figure 3. T Cell and NK Cell Numbers in the Spleen and Liver of T. gondii-Infected CCR5
 /  and CCR5
þ/þ Mice in the C57BL/6 and C57BL/6x129
Backgrounds
Cell numbers. T cell and NK cell numbers in spleen (A and C) and liver (B and D) of mice infected with 15 cysts and harvested 7 d PI. Single-cell
suspensions of spleen and hepatic lymphocytes were prepared and phenotyped for the expression of CD3, CD4, CD8, and NK1.1 by FACS analysis. The
experiment was performed twice with similar results (three or four mice per group).
DOI: 10.1371/journal.ppat.0020049.g003
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CCR5 Mediates NK Homing in InfectionNK cell inﬁltration into tissues resulted in decreased IFNc
production in response to T. gondii infection in the CCR5
 / 
mice, which led to down-regulation of IFNc-inducible genes,
such as those encoding CXCL9, CXCL10, and CXCL11.
CCR5 Acts Downstream of IL-12
CCR5
 /  mice are known to have a diminished IL-12
response following T. gondii infection [21]. As IL-12 is
important for NK cell function [22], a decrease in NK cell
function in T. gondii-infected CCR5
 /  mice could be the
result of suboptimal IL-12 production in these animals. To
investigate this possibility, serum IL-12 levels in CCR5
 /  and
wild-type mice in both the C57BL/6 and C57BL/6x129
backgrounds were measured before infection and at days 3,
5, and 9 post-oral infection with T. gondii (Figure 7). We found
a similar IL-12 serum response in CCR5
 / and wild-type mice
in the C57BL/6 background. Baseline levels were the same in
wild-type and CCR5
 /  mice, and following infection serum
IL-12 levels peaked on day 5 at 15–20 ng/ml in both wild-type
and CCR5
 / in the C57BL/6 background. Thus, in this genetic
background the diminished NK cell response could not be
accounted for by a blunted IL-12 response. However, as
reported [21], CCR5
 /  mice in the C57BL/6x129 background
had an approximately 50% reduction in the serum IL-12
response following T. gondii infection, with levels on day 9 PI
of 12 ng/ml (6 3.2 ng/ml) in wild-type mice and 7.6 ng/ml
(6 1.7 ng/ml) in CCR5
 /  mice (Figure 7B). Thus, in the
C57BL/6x129 background, a blunted IL-12 response may have
contributed to the increased parasite burden seen in these
CCR5
 /  mice on day 14 (Figure 2C).
To determine whether the increased susceptibility of
CCR5
 /  mice in the C57BL/6x129 background was related
to impaired IL-12 production, the effect of daily exogenous
IL-12 therapy on mortality was determined (Figure 8A). IL-12
administration had no effect on the survival of CCR5
 /  mice,
and the mortality and parasite load in these animals was
indistinguishable from those in untreated CCR5
 /  mice
Figure 4. CD4
þ and CD8
þ T Cell T. gondii-Induced Proliferation and IFNc Production
(A and B) Proliferation. Magnetically purified positively selected CD4
þ(A) and CD8
þ(B) T cells (.95% pure) isolated from the spleens of C57BL/6x129 on
day 7 PI. Cells were stimulated either with ConA (2.5 lg/ml) or Toxoplasma lysate antigen (15 lg/ml). After 72 h incubation, proliferation was measured
by
3H thymidine incorporation. Data are represented as mean cpm 6 standard deviation and are representative of two experiments.
(C and D) IFNc secretion. 10
6 purified CD4
þ (C) and CD8
þ (D) T cells from 7 d infected C57BL/6x129 mice were cultured in presence of 15 lg/ml of
Toxoplasma lysate antigen and irradiated feeder cells (5 3 10
5 cells/well) in 24-well plates. After 72 h of incubation the supernatants were collected,
centrifuged, and assayed for IFNc production by ELISA.
(E) Intracellular IFNc production. Female CCR5 /  (5–8 wk old) and wild-type mice were infected perorally with T. gondii cysts and splenocytes were
harvested at day 7 PI, pooled (three mice per group), and cultured in vitro with phorbol 12-myristate 13-acetate, ionomycin, and monensin for 4 h. The
cultured cells were stained for CD4 or CD8 before intracellular staining for IFNc. Data are presented as percentage (mean 6 standard deviation) of CD4
þ
or CD8
þ T cells positive for IFNc and are pooled from two experiments.
DOI: 10.1371/journal.ppat.0020049.g004
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CCR5 Mediates NK Homing in Infection(Figure 8A and 8B). The bioactivity of the cytokine was
further tested by administering IL-12 to wild-type mice
infected intraperitoneally with an LD100 dose of T. gondii
tachyzoites. Treatment of these animals with daily exogenous
IL-12 protected them from lethal infection (unpublished
data), in agreement with a previous report [23].
To further establish that the effect of CCR5-deﬁciency on
the NK cell response observed in T. gondii-infected mice in
the C57BL/6x129 background occurred downstream of IL-12,
we evaluated the NK cell tissue response in IL-12 reconsti-
tution experiments in which we treated wild-type and CCR5
 / 
mice with daily injections of IL-12 following T. gondii
infection. As expected, IL-12 treatment increased NK cell
numbers in the spleen and liver in infected wild-type mice
compared to non-IL-12 treated wild-type controls (Figure 8C
and 8D), demonstrating that IL-12 administered in this
manner is biologically active, as has been previously reported
[23]. In marked contrast, however, IL-12 had no effect on NK
cell numbers in the spleen (Figure 8C) or liver (Figure 8D) of
infected CCR5
 /  mice. In these mice, however, IL-12
increased the number of NK cells in the blood (Figure 8E),
demonstrating that CCR5
 /  mice responded to IL-12
therapy, but were unable to recruit these mobilized NK cells
into tissue. These data establish that the impaired immune
response to T. gondii seen in CCR5
 /  mice is not solely the
result of an impaired ability to generate IL-12, but is also the
result of an inability to effectively mobilize NK cells into
infected tissue.
Figure 5. NK and NK T Cell Numbers in T. gondii-Infected CCR5
 /  and CCR5
þ/þ Mice in the C57BL/6 and C57BL/6x129 Backgrounds
CCR5
þ/þ and CCR5
 /  mice in C57BL/6 and C57BL/6 3 129 backgrounds (three mice per group) were infected with 15 T. gondii cysts. At day 7 PI,
lymphocytes from spleen (A and E), liver (B and F), blood (C and G), and mesenteric lymph nodes (D) were isolated and phenotyped for CD3
þ and
NK1.1
þ by FACS analysis. NK1.1
þCD3
  and NK1.1
þCD3
þ cell numbers are graphed. The experiment was performed twice with similar results.
DOI: 10.1371/journal.ppat.0020049.g005
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CCR5 Mediates NK Homing in InfectionFigure 6. Expression of CCR5 and CXCR3 Chemokine Ligands and IFNc in T. gondii-Infected Mice
Quantitative PCR was performed on total RNA isolated from spleen, lung, liver, and small intestine of wild-type control and CCR5
 /  C57BL/6 mice
(female, 5–6 wk old, three or four mice per group) infected orally with 15–50 cysts of 76K strain of T. gondii. Tissues were harvested from uninfected and
at days 3, 5, and 7 PI. Data are displayed as copies of cytokine or chemokine per copies of GAPDH, with wild type in black bars and CCR5
 / in hatched
bars 6 standard error of the mean. Statistics were performed using Student’s t-test. Sets of symbols: * indicates comparisons with uninfected wild type,
^indicates comparisons between days 5 and 7 PI; and # indicates comparisons between wild type and CCR5
 / .*p , 0.05, ** p , 0.01, *** p , 0.001,^p
, 0.05,^^ p , 0.01,^^^ p , 0.001, # p , 0.05, ## p , 0.01, ### p , 0.001.
DOI: 10.1371/journal.ppat.0020049.g006
Figure 7. Serum IL-12 Levels for Wild-Type and CCR5
 /  Mice
Wild-type (WT) and CCR5
 /  (CCR5 KO) mice in the C57BL/6 background (A) and C57BL/6x129 background (B) are represented. Serum IL-12 levels were
measured by ELISA before infection or at days 3, 5, and 9 PI with 50 cysts of strain 76K T. gondii. Each data point was measured in duplicate and
indicates IL-12 levels for an individual mouse. The bar represents the average at each time point. Statistics were performed using Student’s t-test.
DOI: 10.1371/journal.ppat.0020049.g007
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CCR5 Mediates NK Homing in InfectionNK Cell Depletion Recapitulates the CCR5
 /  Phenotype
Our data suggest that CCR5 expression on NK cells is
critical for NK cell trafﬁcking into tissue in response to T.
gondii infection, and that this impairment in NK cell
trafﬁcking into tissue explains the phenotype observed in
CCR5
 /  mice. If this is the main reason for the observed
phenotype, then it follows that NK cell depletion of wild-type
mice should reveal a similar phenotype following T. gondii
infection. We therefore depleted NK cells in wild-type C57BL/
6 mice using anti-asialo GM1 antibody treatment to deter-
mine whether depletion of NK cell results in a reduced
inﬂammatory response similar to CCR5
 /  mice in this
genetic background. As shown in Figure 9A, while C57BL/6
wild-type mice treated with control antibody died by day 9 PI,
the majority of NK cell-depleted mice survived until day 21
PI. To demonstrate that the protective effect of NK cell
depletion on early mortality was the result of an attenuated
tissue hyperinﬂammatory response, tissues were analyzed
histopathologically (Figure 9B). As expected, mice treated
with control antibody exhibited extensive necrosis of the
ileum of small bowel, with acute inﬂammation, including
polymorphonuclear cells in the lamina propria. The liver
showed marked conﬂuent fatty degeneration of hepatocytes,
with small inﬂammatory nodules in the parenchyma (Figure
9B). In contrast, the small intestines of anti-asialo GM1-
treated mice revealed no necrosis, with preservation of
epithelial cells within the villi. Livers of these NK cell-
depleted mice showed an acute inﬂammatory inﬁltrate, which
was compatible with acute infection seen in T. gondii-infected
mice that do not have a hyperimmune inﬂammatory
response. To establish that mortality at the later time points
in the NK cell-depleted mice was due to infection and not a
tissue hyperimmune response, tissues (spleen, brain, and
liver) from NK cell-depleted mice were analyzed for parasite
burden. On day 7 PI, when control antibody-treated C57BL/6
mice were beginning to succumb to their infection but NK
Figure 8. Survival and NK Cell Response following Exogenous IL-12 Treatment of CCR5
þ/þ and CCR5
 /  Mice
(A and B) Effect of IL-12 administration on survival in the C57BL/6 x129 background. CCR5
 /  and CCR5
þ/þ mice (three mice per group) were treated
with recombinant murine IL-12 (0.33 lg/mouse) daily intraperitoneally starting one day prior to infection with T. gondii. Uninfected controls treated
with either IL-12 or saline were included in the study (six mice per group). Mice were challenged orally with 50 cysts and survival was monitored daily.
Parasite load (B) was determined for mice described in (A). Mice were sacrificed on day 14 PI (three mice per group), and tissues (brain, liver, small
intestine, and spleen) analyzed for parasite load by competitive DNA PCR.
(C–E) Effect of exogenous IL-12 treatment on the NK cell response. CCR5
 / and CCR5
þ/þmice were infected orally with the 76K strain of T. gondii (three
mice per group) and were treated with recombinant murine IL-12 (0.33 lg/mouse) via intraperitoneal route starting one day prior to infection.
Uninfected controls treated with either IL-12 or saline were included in the study (three mice per group). At day 7 PI, single-cell suspensions from the
spleens (C), and lymphocytes from liver (D) and blood (E) were prepared and cells were analyzed for the expression of the NK1.1 marker by FACS
(experiment was performed twice with similar results).
DOI: 10.1371/journal.ppat.0020049.g008
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CCR5 Mediates NK Homing in Infectioncell-depleted mice were not, parasite load was low in both
groups. However, by day 18 PI, when NK cell-depleted mice
were beginning to succumb to their infection, tissue parasite
load in these mice had increased several hundred-fold (Figure
9C). All control antibody-treated infected mice died by day 10
PI and were therefore not available for analysis on day 18 PI.
As a further control, we found that anti-asialo GM1 antibody
treatment of uninfected mice had no effect on mortality
(unpublished data). To determine whether the increased
mortality and tissue hyperimmune response in C57BL/6 mice
was the result of CCR5-mediated NK cell trafﬁcking, we
adoptively transferred wild-type and CCR5
 /  NK cells into
CCR5
 /  mice followed by T. gondii challenge. As can be seen
in Figure 9D, adoptive transfer of wild-type NK cells
increased the susceptibility of CCR5
 /  C57BL/6 mice to T.
gondii, and this was associated with a hyperimmune response
in the small intestine (Figure 9E) and liver (unpublished data),
which was not seen in CCR5
 /  mice that received CCR5
 / 
NK cells.
To determine whether absence of NK cells can also affect
the outcome of T. gondii infection in the C57BL/6 x129
background, wild-type and CCR5
 /  mice in this background
were depleted of NK cells using an anti-asialo GM1 antibody
treatment. Depletion of NK cells resulted in mice that had a
dose-dependent increase in mortality following infection.
Thus, while NK cell depletion had no effect on survival
following an infection with 20 cysts, infection with 50 cysts
resulted in 90% mortality in NK cell-depleted mice (Figure
10A). No increase in mortality was observed in mice treated
with a control antibody (Figure 10A). Thus, depletion of NK
cells recapitulated the phenotypes seen in CCR5
 /  mice in
both the C57BL/6 and C57BL/6x129 backgrounds following T.
gondii infection.
Adoptive Transfer of Wild-Type NK Cells Confers
Resistance in CCR5
 /  Mice
To further determine whether CCR5 expression on NK
cells was critical for host resistance to T. gondii, adoptive
transfer studies were performed using CCR5
 /  mice in the
C57BL/6x129 background as the recipients, and the following
syngeneic cell preparations as donors: wild-type and CCR5
 / 
splenocytes, NK cell-depleted wild-type splenocytes, and
puriﬁed wild-type and CCR5
 /  NK cells. Spleen cells from
uninfected wild-type and CCR5
 /  mice were depleted of NK
cells by magnetic separation using the NK marker DX5, which
was also used to positively select NK cells. DX5 expression has
been reported to be restricted to NK cells and a minority of
activated T cells and has been used to purify NK cells to
evaluate their functional activities [24]. Since we isolated
DX5
þ cells from spleens harvested from naı ¨ve mice, it is
unlikely that there were signiﬁcant numbers of activated T
cells in the donor cell population. CCR5
 /  mice in the
C57BL/6x129 background were injected intravenously with
10
7 DX5
þ NK cells or DX5
  splenocytes or equal volume of
saline. At 48 h after transfer, recipients were orally
challenged with 20 or 50 cysts. Infection with 20 cysts
produced no mortality in any group (unpublished data).
However, infection with 50 cysts induced 100% mortality by
day 16 PI in mice that received DX5-depleted splenocytes or
saline (Figure 10B). In contrast, mice that received DX5
þwild-
type cells controlled their infection and survived. Conversely,
DX5
þ cells from CCR5
 /  donors were unable to protect
recipient mice against a high dose infection (Figure 10B). To
investigate whether the survival of recipients of DX5
þ wild-
type NK cells was the result of decreased parasite replication,
we determined the tissue parasite load following adoptive
transfer of wild-type DX5
þ and DX5
  cells and CCR5
 /  DX5
þ
cells (Figure 10C). We found reduced parasite loads in the
brain, liver, and small intestine of mice that received CCR5
þ/þ
DX5
þ cells but not CCR5
 /  DX5
þ cells or CCR5
þ/þ DX5
  cells.
These data demonstrate that CCR5 function on NK cells is
critical for host resistance to T. gondii.
Impaired Homing of Adoptively Transferred CCR5
 /  NK
Cells
To establish that CCR5 plays an important role in NK cell
trafﬁcking, congenic (CD45.1/CD45.2) C57BL/6 mice were
used for adoptive transfer experiments. Puriﬁed NK cells (23
10
6 DX5
þ) isolated from naı ¨ve wild-type and CCR5
 /  CD45.2
mice were transferred into congenic CD45.1 mice by intra-
venous injection. At 48 h post-transfer, recipient mice were
challenged orally with 50 cysts of T. gondii. Recipients were
sacriﬁced 3 d after the challenge and organs (spleen and liver)
were analyzed by FACS for the presence of CD45.2 cells. In
comparison to transferred wild-type NK cells, transferred
CCR5
 /  NK cells had a signiﬁcantly reduced ability to
migrate into the spleen (p ¼ 0.002) and liver (p ¼ 0.05) of
recipient wild-type mice (Figure 10D). These data demon-
strate that CCR5 expression on NK cells plays an important
role their homing to T. gondii-infected organs.
CCR5 Agonists Induce NK Cell Chemotaxis
Our data suggest that NK cell recruitment in vivo in
response to T. gondii infection is mediated by CCR5 expressed
on NK cells. CCR5 has been reported to be highly expressed
on murine NK cells [14]. To directly test whether CCR5 is
functional on NK cells, we puriﬁed NK cells from the spleens
of mice using DX5, an NK cell marker. We found that DX5
þ
NK cells had a robust chemotaxis response to CCL4/MIP-1b,a
CCR5-speciﬁc agonist (Figure 10E). In contrast, DX5
 
splenocytes had no chemotactic response to CCL4, but
responded robustly to the positive control CXCR3 agonist
CXCL11/I-TAC. These data demonstrate that CCR5 is func-
tional on NK cells and plays an important role in NK cell
trafﬁcking in vivo. Furthermore, we analyzed these DX5
þ NK
cells and DX5
  splenocytes for chemokine receptor mRNA
expression by quantitative real-time PCR. As shown in Figure
10F, although NK cells and NK-depleted cells express similar
mRNA levels of CXCR3, NK cells were enriched for CCR5
mRNA compared to NK-depleted cells, conﬁrming the
chemotaxis data, which demonstrated functional CCR5
expression on NK cells. Moreover, NK cells were enriched
for CX3CR1, but had low CCR4 levels, a proﬁle consistent
with that of human NK cells [12]
Discussion
The ﬁndings presented here demonstrate that CCR5 is a
critical NK cell homing receptor, controlling NK cell
trafﬁcking into tissues in a murine model of T. gondii
infection. While CCR5-deﬁcient C57BL/6 mice had an early
burst of CCR5 ligand production, their inability to mount a
tissue NK cell response resulted in decreased tissue inﬂam-
mation characterized by diminished IFNc and subsequent
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CCR5 Mediates NK Homing in InfectionFigure 9. Effect of NK Cells on Survival following T. gondii Infection of C57BL/6 Mice
(A–B) NK cell depletion of wild type. C57BL/6 mice were infected orally with 50 cysts. One day before and every day after infection mice were injected
intraperitoneally with anti-asialo GM1 antibody. The treatment was continued for the duration of the experiment. Eight animals were treated per group,
and data are representative of two separate experiments. Survival (A) and histopathology (B) of NK cell depleted and nondepleted T. gondii-infected
CCR5
þ/þC57BL6 mice. Photomicrographs of hematoxylin and eosin-stained liver and ileum of small intestine isolated from infected anti-asialo GM1 and
control antibody-treated mice. NK cell-depleted mice had essentially normal small bowel morphology, and the livers showed an acute inflammatory
response compatible with acute T. gondii infection. In nondepleted wild-type mice, the small bowel showed extensive, scattered, superficial necrosis,
with acute inflammation, including polymorphonuclear cells in the lamina propria. The livers show marked, confluent fatty degeneration of
hepatocytes, with small inflammatory nodules in the parenchyma consistent with a hyperimmune inflammatory response. Size bars: liver, 20 lm; small
bowel 100 lm. The arrow indicates an area of superficial necrosis of epithelial cells.
(C) Parasite load. Wild-type C57BL/6 mice were infected with 50 cysts orally and NK cell depletion performed as described above. At day 7 and 18 PI
mice (three per group) were sacrificed and tissues (brain, liver, and spleen) analyzed for parasite load by competitive DNA PCR.
(D–E) NK cell adoptive transfer. NK cells from CCR5
 / and wild-type C57BL/6 mice were isolated and 10
7 purified NK cells were injected to naı ¨ve CCR5
 / 
mice. Recipients were subsequently challenged with 50 cysts of T. gondii. Six animals were treated per group, and data represent two separate
experiments. Survival (D) and histopathology (E) of T. gondii-infected CCR5
 /  C57BL/6 treated with either CCR5
 /  or CCR5
þ/þ NK cells. Mice described
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CCR5 Mediates NK Homing in Infectionchemokine expression in the tissues. This impaired inﬂam-
matory response protected the mice from the lethal hyper-
immune response evoked by T. gondii in the C57BL/6
background. As a result, however, CCR5
 /  mice had an
increased parasite burden and thus succumbed to infection
when challenged with high doses of T. gondii cysts in a genetic
background (C57BL/6x129) that is not susceptible to the
hyperimmune response. The impaired immune response to
acute T. gondii infection in CCR5
 /  was characterized by
deﬁcient recruitment of NK cells into the tissue. Adoptive
transfer of CCR5
þ/þ NK cells into CCR5
 /  C57BL/6x129 mice
restored their natural resistance to T. gondii infection and
demonstrated the CCR5 dependence for NK cell trafﬁcking
into infected tissue. These studies establish CCR5 as a critical
receptor for NK cell trafﬁcking and innate host defense.
NK cells are produced in the bone marrow and circulate in
the blood. In response to infection or inﬂammation, NK cells
leave the circulation and enter the tissues where they play an
essential role in early innate host defense. The molecular
signals that control the recruitment of NK cells into tissues
are not understood. Our study clearly establishes CCR5 as an
important receptor guiding NK trafﬁcking into T. gondii-
infected tissue. In orally infected animals we found markedly
reduced numbers of CCR5
 /  NK cells in spleen and liver,
tissues in which we observed an early induction of CCR5
ligand expression. We did not observe an increase in NK cell
inﬂux into the small intestine of either wild-type or CCR5
 / 
mice. Interestingly, we found no signiﬁcant expression of
CCR5 ligands in this tissue following infection until day 7;
even then it was much less than that observed in the spleen,
lung, and liver. We also found that CCR5
 /  NK cells
accumulated in the blood and mesenteric lymph node of
infected animals. It was recently shown that CXCR3 plays an
important role in NK cell trafﬁcking into inﬂamed lymph
nodes [25]. We suspect that NK cells can enter the infected
lymph node via CXCR3 but cannot move out into the tissue
in the absence of CCR5 signaling.
Adoptive transfer experiments conﬁrmed that CCR5
expression was required for NK cell trafﬁcking into infected
tissue. CCR5
 /  mice have normal NK cell numbers in the
uterus, which may suggest a difference in the control of
homeostatic NK cell trafﬁcking versus NK cell trafﬁcking in
response to an infection or differences in organ-speciﬁc NK
cell trafﬁcking [26]. CCR5 has been shown to be homoge-
neously highly expressed on murine NK cells (DX5
þ, CD11b
þ,
CD4
 , CD8
 ) [14], and we found that CCR5 was markedly
enriched on DX5
þ splenocytes compared to DX5
  spleno-
cytes, and that DX5
þ splenocytes migrated in response to a
gradient of CCL4/MIP-1b, a CCR5-speciﬁc agonist, while
DX5
 splenocytes did not. Expression of CCR5 on murine NK
cells may, however, differ from human NK cells, in which
CCR5 is highly expressed only on a subset (CD56
þCD16
 )o f
NK cells [12]. However, CCL3/MIP-1a has been shown to
chemoattract human NK cells [27], and CCL3/MIP-1a was
identiﬁed as the major NK cell chemoattractant released
from cytotrophoblasts [28]. These latter studies suggest that
CCR5 may also play an important role in human NK cell
trafﬁcking.
Our study demonstrates an important role for CCR5 in NK
cell trafﬁcking to T. gondii-infected liver and spleen. In doing
so, our data also revealed an unappreciated role of the NK
cell in regulating tissue inﬂammation induced by T. gondii.I t
has been generally believed that IFNc-producing CD4
þT cells
in T. gondii-infected mice are the primary mediators of the
hyperinﬂammatory response [20]. However, recent studies in
our laboratory have demonstrated that CCR1
 /  mice in the
C57BL/6 background had a defect in neutrophil trafﬁcking,
which also resulted in a reduced hyperimmune response
following T. gondii infection [3]. Thus, it appears that in
addition to CD4
þT cells, innate immune cells such as NK cells
and neutrophils also contribute to the hyperimmune re-
sponse in T. gondii-infected animals. The important role of
NK cells during early Toxoplasma infection has been well
described. Administration of IL-12 to normal immunocom-
petent mice enabled them to tolerate lethal infective doses of
T. gondii [23]. In the same studies, depletion of NK cells
reversed the protective effect of IL-12. Similarly, IL-12
treatment of SCID mice, which lack T and B cells, enabled
them to survive longer with a T. gondii infection [6]. It is
believed that NK cells are an important early source of IFNc
during acute T. gondii infection [8]. Our current data support
these ﬁndings regarding an important role for NK cells
during acute Toxoplasma infection. Absence of an optimal NK
cell response at the site of infection in the CCR5
 /  mice lead
to a defective clearance of parasites, resulting in increased
mortality. Although less critical than T cells, which are
needed for long-term host survival [29], NK cells play an
essential role in host survival following challenge with a high
parasite load. In the present study, we observed that CCR5
 / 
mice on the C57BL/6x129 background, when challenged
orally with 20 cysts, could survive the infection. However,
when the dose was increased to 50 cysts, optimal NK cell
migration to infected sites was needed, without which the
host was unable to survive. Furthermore, transfer of
splenocytes as well as puriﬁed NK cells from uninfected
wild-type mice protected CCR5
 /  mice against this high
challenge, while the transfer of NK cell-depleted splenocytes
did not confer protection in these mice. These data
demonstrate that in the presence of high doses of T. gondii,
NK cells are required for parasite clearance, and their
absence ultimately results in elevated parasite burden in the
tissues, which leads to increased mortality.
CCR5 has been implicated in the host response to T. gondii.
The CCR5 ligands CCL3/MIP-1a and CCL4/MIP-1b have been
shown to be induced in splenic endothelial cells and dendritic
cells within 2 h of the injection of soluble T. gondii antigen
[21]. CCL3 and CCL4 were also shown to be induced in the
small intestine 7 d following T. gondii infection [30]. In this
latter study, adoptive transfer of CCR5
 /  CD8a
þ intra-
epithelial lymphocytes from T. gondii-infected mice into naive
animals had reduced ability to migrate into the intestine of
recipient mice following infection. As intraepithelial lym-
above (two mice each) were sacrificed on day 9 and ileum isolated and stained with hematoxylin and eosin. In (E), small bowel of CCR5
 /  C57BL/6
recipients treated with CCR5
 / NK cells (i) demonstrates preservation of the mucosa, as seen in large areas of the bowel wall. Bar, 100 lm. In contrast, in
CCR5
 /  C57BL/6 recipients treated with wild-type NK cells (ii), the small bowel mucosa is characterized with superficial necrosis and with an
inflammatory cell infiltrate of in the lamina propria, typical of hyperinflammatory response. Bar, 100 lm.
DOI: 10.1371/journal.ppat.0020049.g009
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CCR5 Mediates NK Homing in InfectionFigure 10. Effect of NK Cells on Survival following T. gondii Infection of C57BL/6x129 Mice and CCR5-Dependent Homing of NK cells
(A) NK cell depletion of wild-type C57BL/6x129 mice. Mice were infected orally with 20 or 50 cysts of T. gondii. One day prior to infection and then three
times a week for 2 wk, mice were injected intraperitoneally with anti-asialo GM1 antibody or a control rabbit IgG. Data represent two separate
experiments (six mice per group).
(B) Adoptive transfer of NK cells protects CCR5
 /  mice in the C57BL/6 x129 background against T. gondii infection. DX5
þ cells from spleens of
uninfected C57BL/6x129 wild-type and CCR5
 /  mice were isolated by magnetic separation. 1 3 10
7 DX5
þ NK cells and the same number of DX5
 
splenocytes or an equal volume of saline were injected intravenously into naı ¨ve syngeneic C57BL/6x129 CCR5
 / animals. At 48 h after transfer, animals
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CCR5 Mediates NK Homing in Infectionphocytes are unconventional lymphocytes, it is difﬁcult to
compare these studies with our observations and we did not
speciﬁcally evaluate lymphocyte populations in the small
intestine. Furthermore, cyclophilin-18, a soluble T. gondii
protein, was shown to induce the production of IL-12
through activation of CCR5 [31]. However, neutrophils
containing prestored IL-12 are also an important source of
IL-12 [2], which may be especially important in the CCR5-
deﬁcient mice. Our study does not directly address this issue,
but we found that CCR5 must also act downstream of IL-12.
We observed that CCR5
 /  mice in the C57BL/6 background
had an equivalent increase in serum IL-12 levels following T.
gondii infection. Thus, the phenotype that we observed in
CCR5
 /  mice in this background—a blunted hyperimmune
response and a decrease in NK cell recruitment into tissues—
could not be explained by a blunted IL-12 response. We did,
however, conﬁrm the ﬁndings of Aliberti et al. [21], who
reported an approximately 50% decrease in serum IL-12
levels in CCR5
 /  C57BL/6x129 mice following T. gondii
infection. Thus CCR5-dependent IL-12 production may play
a role in controlling parasite replication in CCR5
 /  mice in
C57BL/6x129 background. However, we do not believe that
this partial reduction in serum IL-12 fully accounts for the
dramatic phenotype we observed for CCR5
 /  mice in this
background. We could not restore resistance of CCR5
 / mice
to T. gondii infection with exogenous IL-12 treatment.
Furthermore, exogenous IL-12 did not reverse the defect in
NK cell trafﬁcking we observed in CCR5
 / mice, even though
IL-12 augmented NK numbers recovered from the spleen of
uninfected and infected wild-type mice. Furthermore, exog-
enous IL-12 increased the resistance of wild-type mice to a
lethal T. gondii challenge. Thus, taken together, these data
support an additional and major role for CCR5 downstream
of IL-12 production in the recruitment of NK cells into T.
gondii-infected tissue.
The chemokine system is a complex cytokine network that
controls the trafﬁcking of leukocytes. A functional appreci-
ation for the roles of individual members of this superfamily
has come from studies using genetically deﬁcient mice or
spontaneous mutations in humans. CCR5 is the best example
of this paradigm, with the generation of CCR5-deﬁcient mice
and the identiﬁcation of a CCR5 null mutation in the human
population. CCR5-deﬁcient mice have been described and
characterized as impaired in their ability to handle infection
with Listeria [32] and inﬂuenza A virus [33], and as having
diminished IFNc production in response to Leishmania
donovani infection [34]. These mice have also been shown to
be protected from lipopolysaccharide-induced endotoxemia
[32] and dextran-sulfate injury of the bowel [35].
Humans with a naturally occurring null mutation in CCR5
(CCR5-D32) are resistant to HIV-1 infection, and lymphocytes
from these individuals were resistant to ‘‘M’’-tropic HIV-1
entry [36–40]. Since these important discoveries, it has been
realized that these CCR5 null individuals, which represent
about 1% of persons of European decent, would be of
interest in terms of their susceptibility to infectious and
inﬂammatory diseases. Studies examining disease suscepti-
bility in these CCR5-D32 homozygotes are ongoing and some
studies have already been published on rheumatoid arthritis
[41–43], systemic lupus erythematosis [41], inﬂammatory
bowel disease [44], and multiple sclerosis [45,46] in these
persons. To date, of all these conditions only rheumatoid
arthritis appears to be affected in CCR5 individuals; a slight
reduction in severity was observed. However, CCR5-D32
homozygotes are ideal ‘‘models’’ in which to study this
receptor in the function of NK cells and in the host response
to pathogens such as T. gondii.
Our study also raises concern about the potential compli-
cation of impaired NK cell function for the clinical use of
CCR5 antagonists currently being developed as therapeutics
for HIV-1 and inﬂammatory diseases. This may be of
particular concern for HIV-1 infected patients coinfected
with T. gondii or for those who acquire an acute T. gondii
infection while taking a CCR5 antagonist. Our results suggest
that the blockade of CCR5 through the use of antagonists may
prevent NK cell trafﬁcking to tissue sites of infection
following acute T. gondii and, thus, affect immune control of
T. gondii.
Our study highlights two important points regarding the
biology of chemokines and their receptors. First, although in
vitro studies have implied the existence of redundancy in the
chemokine system, as evidenced by the fact that NK cells
express multiple chemokine receptors and respond to multi-
ple chemokines, studies such as ours have revealed that
individual chemokines and chemokine receptors play im-
portant, nonredundant roles in vivo. Second, our study
dramatically underscores the importance of genetic back-
ground when examining the effects of a chemokine or
chemokine receptor gene in a complex biological process,
such as host defense against pathogens. In the pure C57BL/6
background, the absence of CCR5 was protective, because it
led to a diminished hyperimmune response, which in the
C57BL/6 background can be lethal. However, in the mixed
C57BL/6x129 background, which is not susceptible to the
hyperimmune response, and can otherwise withstand high
were challenged orally with 50 cysts of T. gondii and survival monitored daily. The experiment was performed twice with similar results, and
representative data are shown.
(C) Parasite load. Mice described in (B) (three mice per group) were sacrificed on day 12 and tissues (brain, liver, and spleen) analyzed for parasite load
by competitive DNA PCR.
(D) CCR5-dependent homing of adoptively transferred NK cells. DX5
þ CD45.2
þ cells from uninfected CCR5
 /  and wild-type mice were isolated by
affinity purification. 2 3 10
6 purified (CD45.2) DX5
þ cells were transferred to naı ¨ve congenic CD45.1 mice. One group (three mice per group) received
DX5
þ CD45.2
þ cells from wild-type mice, while the other group was injected with DX5
þ CD45.2
þ cells isolated from CCR5
 /  mice. Recipients were
subsequently challenged with 50 cysts orally and 3 d later animals were sacrificed. Splenocytes and hepatocytes isolated from the recipients were
stained with FITC-labeled anti-CD45.2 antibody and number of transferred CD45.2
þ cells determined by flow cytometry.
(E) CCR5-dependent NK cell chemotaxis. NK cells respond to the CCR5 specific agonist CCL4 (MIP-1b). Purified DX5
þ splenocytes (NK cells) and DX5-
depleted splenocytes (NK cell-depleted) were analyzed in transwell chemotaxis assays. Chemotaxis and chemokinesis (control) of NK cells and NK-
depleted splenocytes were tested at the indicated CCL4 (MIP-1b CCR5-specific agonist) and CXCL11 (I-TAC) (CXCR3-specific agonist) concentrations.
Each data point is the mean 6 standard deviation of triplicate measurements and represents three independent experiments.
(F) DX5
þ NK cells express CCR5 mRNA. DX5
þ NK cells and DX5
  C57BL/6 splenocytes were analyzed for chemokine receptor expression profile by
quantitative real-time PCR. These data represent three experiments.
DOI: 10.1371/journal.ppat.0020049.g010
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to increased mortality from uncontrolled parasite growth.
Thus, the absence of CCR5 and the resultant impaired
recruitment of IFNc-secreting NK cells has a different
outcome on the host response to T. gondii depending on the
genetic background.
Based on our current data and prior studies [15,16,47], a
picture is emerging regarding the critical role of chemokines
in linking the innate and acquired immune response to
pathogens such as T. gondii. T. gondii infection induces an early
and rapid burst in CCL3 and CCL4 production in speciﬁc
infected tissue, such as the spleen, liver, and lung. CCL3 and
CCL4 recruit IFNc-secreting NK cells into infected tissue in a
CCR5-dependent manner. IFNc induces the production of
chemokines, including CXCL10, from resident tissue cells
that attract antigen-speciﬁc CD4
þand CD8
þlymphocytes into
infected tissue to establish organ-speciﬁc immunity [17].
Thus, analogous to antiviral defenses described for cytomega-
lovirus [15,16,47], the host response to T. gondii requires a
chemokine-to-cytokine-to-chemokine cascade. This likely
represents a general principle that links the innate and
acquired immune response to intracellular pathogens, which
is essential for protective immunity.
Based on these ﬁndings, we conclude that the presence of
CCR5 is required for the induction of the inﬂammatory
response during T. gondii infection. The absence of this
response, although initially advantageous in the C57BL/6
background because of the absence of the hyperimmune
response, leads to uncontrolled parasite multiplication and
ultimate death of the infected host in the C57BL/6x129
background.
Materials and Methods
Mice and parasites. CCR5
 /  mice in the C57BL/6x129 background
were generated as previously described and wild-type littermates
were used as controls [48]. The CCR5
 /  transgene was also back-
crossed eight generations into the C57BL/6 background. Wild-type
C57BL/6 used for the backcross were used as controls. Congenic
CD45.1 mice were obtained from Jackson laboratories (Bar Harbor,
Maine, United States). Mice were challenged perorally with the 76K
strain of T. gondii (kindly provided by Dr. Daniel Bout, Tours, France).
This strain is maintained by continuous oral passage of cysts.
Quantitation of parasite burden. Tissues (small intestine, spleen,
liver, lung, and brain) from T. gondii-infected animals were collected
at days 7 or 15 PI. DNA was extracted from tissues using the QiaAmp
tissue kit (Qiagen, Valencia, California, United States), and 400 ng of
each sample was analyzed by quantitative PCR. Ampliﬁcation of
parasite DNA was performed using primers speciﬁc for a 35-fold
repetitive sequence of the T. gondii B1 gene (59-GGAACTG-
CATCCGTTCATGAG-39 and 59-TCTTTAAAGCTTCGTGGT C-39),
which is found in all known parasite strains [49]. A 134 bp
competitive internal standard containing the same primer template
sequences as the 194 bp B1 PCR fragment was also synthesized [50].
Ampliﬁcation of this 194 bp segment of the B1 gene and the 134 bp
segment of the internal standard was performed using in a 50 ll
reaction mixture containing 1.25 units of AmpliTaq DNA polymer-
ase, 13buffer (Perkin Elmer, Wellesley, California, United States), 0.2
mM each of dGTP, dATP, dTTP, and dCTP, and 0.4 lM of each B1
primer. For each reaction a known amount of DNA from the tissues
was ampliﬁed with varying amounts of the internal standard. Parasite
loads were estimated by comparison to the internal controls. To
determine the parasite load in infected tissues, PCR was performed
under the same conditions using a known number of parasites. The
level of internal control was calculated per parasite [50].
Histopathological analysis. Tissues from infected CCR5
 /  animals
and control C57BL/6 animals were ﬁxed in 10% buffered formalin,
parafﬁn processed, and used to prepare 5 lm histological sections.
Sections were stained with hematoxylin and eosin and photographed
on an Olympus Van Ox microscope (Olympus, Tokyo, Japan) with
Kodak Elite 100 ﬁlm. The resulting images were digitized with a
Polaroid Sprint scanner and processed using Adobe Photoshop
software.
Phenotypic analysis. Single-cell suspensions of splenocytes were
prepared using standard procedures, and hepatic lymphocytes were
isolated using a modiﬁcation of published methods [51]. In brief,
livers were perfused with sterile PBS prior to excision to remove
blood elements. Excised livers were minced and passed through a
mesh screen. The cells were washed with PBS and subjected to density
gradient centrifugation on Percoll (Sigma, St. Louis, Missouri, United
States) to isolate the lymphocyte population. For isolating peripheral
blood lymphocytes, blood was collected by cardiac puncture in a
microcentrifuge tube containing heparin. About 500–700 ll of blood
was obtained by this method and lysis of red blood cells was
performed using Red Cell Lysis Buffer (Sigma). The cell pellet was
resuspended in PBS containing 1% BSA. Splenocytes, mesenteric
lymph node cells, and hepatic lymphocytes were suspended in PBS
containing 10% FCS, and all the samples were counted in a
hemocytometer prior to staining with the ﬂuorochrome-conjugated
antibodies anti-CD3-FITC, anti-CD8-FITC, anti-NK1.1-PE, and anti-
CD45.2-FITC (clone 104) (all from BD PharMingen, San Diego,
California, United States) and anti-CD4-Red613 (GIBCO BRL, Grand
Island, New York, United States). Two- and three-color ﬂow
cytometry was performed on a FACscan cytometer (Becton Dick-
inson, San Jose, California, United States) and the data were analyzed
using Lysys software (Hewlett-Packard, Palo Alto, California, United
States). The absolute number of positive cells was calculated as
follows: Total number of cells recovered from organ3percentage of
cells staining positive/100.
Proliferation assay. CD4
þ and CD8
þ T cells were puriﬁed from
splenocytes by positive selection using microbeads (Miltenyi Biotec,
Bergisch Gladbach, Germany). The purity of the cells exceeded 95%
as determined by FACS analysis. Puriﬁed cells were cultured in 96-
well plates at the concentration of 2 3 10
5 cells/well in 200 ll. Cells
were stimulated either with ConA (2.5 lg/ml; Sigma) or Toxoplasma
lysate antigen (10 lg/ml) in the presence of 1 3 10
6 irradiated feeder
cells (3,000 rads) obtained from syngeneic mice. After 72 h incubation
at 37 8Ci n5 %C O 2, cells were pulsed with
3H thymidine (0.5 lCi/well)
for 8 h to determine rate of DNA synthesis. Pulsed cells were
harvested on a glass ﬁlter and dried, and radioactive thymidine
incorporation was measured by liquid scintillation.
IFNc assay. CD4
þ and CD8
þ T cells from CCR5
 /  and wild-type
mice were puriﬁed from spleens on day 7 PI. Puriﬁed cells were
cultured at 1 3 10
6 cells/well in 24-well plates in the presence of 1 3
10
6 irradiated feeder cells from naı ¨ve syngeneic mice. Cultures were
stimulated with 10 lg/ml of Toxoplasma lysate antigen, and super-
natants were collected after 72-h stimulations. Supernatants were
analyzed for IFNc by ELISA using mouse IFNc immunoassay kit (R&D
Systems, Minneapolis, Minnesota, United States).
Intracellular IFNc staining. IFNc production by T cells was
evaluated by intracellular staining as previously described [52] using
the Cytoﬁx/CytoPerm kit (BD PharMingen, San Jose, CA). Wild-type
and CCR5
 /  mice (aged 5–8 wk) were infected orally with 20 cysts of
T. gondii. At day 7 PI, spleens were disrupted between glass slides, and
red blood cells were removed by lysis with Red Blood Cell Lysing
Buffer (Sigma). Cells were stimulated in 96 well plates with 10 ng/ml
phorbol 12-myristate 13-acetate (Sigma), 500 ng/ml of ionomycin
(Sigma), and 2 lM monensin (Golgistop; BD PharMingen) for 4 h at 37
8Ci n5 %C O 2. After stimulation, cells were surface-stained with FITC
anti-CD8a, or PE-Cy5 anti-CD4 (eBioscience, San Jose, California,
United States). Intracellular staining was then performed using anti-
IFNc or an isotype-matched control antibody conjugated with PE
(eBioscience). Samples were analyzed by FACS.
Quantitative PCR analysis. Quantitative PCR analysis was per-
formed on total RNA isolated from lung, liver, small intestine, and
spleen of CCR5
 /  and wild-type control mice (females aged 5–6 wk)
infected orally with 15–50 cysts of 76K strain of T. gondii. Tissues were
harvested 3, 5, and 7 days PI. Total RNA was extracted from tissue
using Trizol (Invitrogen, Carlsbad, California, United States) or from
magnetic bead puriﬁed cells using the RNeasy kit (Qiagen). After
DNase I (Invitrogen) treatment, total RNA from each sample was used
as a template for the reverse-transcription reaction. cDNA was
synthesized using oligo(dT)15 and random hexamers. Oligonucleotide
primers were designed using Primer Express software (PE Biosystems,
Foster City, California, United States). QPCR was performed as
described, using the Mx4000 Multiplex Quantitative PCR System
(Stratagene, La Jolla, California, United States) [53]. Emitted
ﬂuorescence for each reaction was measured during the annealing/
extension phase, and ampliﬁcation plots were analyzed using the
MX4000 software version 3.0 (Stratagene). Quantity values (i.e.,
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ﬂuorescence generated by each sample with standard curves of
known quantities, and the calculated number of copies divided by the
number of copies of the constitutively active gene b2-microglobulin
or GAPDH. Primers sets used are posted on our laboratory web site at
http://www.immunologynet.org.
Serum IL-12 p40/p70 ELISA. Serum was collected via tail bleed
from wild-type control and CCR5
 /  mice in both the C57BL/6 and
C57BL/6x129 background either before infection or at days 3, 5, and
9 post oral infection with 50 cysts of 76K strain of T. gondii. IL-12 p40/
p70 ELISA was performed on all samples using an immunoassay kit
(Biolegend, San Diego, California, United States).
Exogenous IL-12 administration. Each mouse was injected intra-
peritoneally with 0.33 lg of recombinant murine IL-12 (Genetics
Institute, Cambridge, Massachusetts, United States) 1 d prior to
infection and then every day thereafter. Control mice were injected
with an equal volume of saline. At day 7 PI, animals were sacriﬁced,
single-cell suspensions from the spleens were prepared, and the cells
were analyzed for the expression of NK1.1 marker by ﬂow cytometry.
NK cell depletion. To deplete NK cells, mice were injected with 50
lg of anti-asialo GM1 antibody (Wako Pure Chemical, Richmond,
Virginia, United States) intraperitoneally starting 1 d prior to
infection. Treatment was continued three times a week for a period
of 2 wk and once weekly there after.
NK cell puriﬁcation and chemotaxis. NK cells were puriﬁed from
C57BL/6 or BALB/c mice as described [54]. Brieﬂy, unactivated
splenocytes were incubated with anti-mouse CD16/CD32 (BD
Pharmingen) and then stained with PE-DX5 mAb (BD Pharmingen),
followed by incubation with magnetic microbeads coated with anti-
PE-Ab (Miltenyi Biotec). DX5
þ cells were isolated by MACS magnetic
cell sorting (Miltenyi Biotec). NK-depleted splenocytes were sus-
pended in RPMI with 1% bovine serum albumin and loaded in
triplicate into a transwell chemotaxis apparatus (ChemoTx, Neuro-
probe, Gaithersburg, Maryland, United States). Chemokines were
placed in the lower wells at various concentrations and, as a control
for chemokinesis, in the upper and lower wells at the same
concentration. After incubation for 2 h at 37 8C, cell counts were
determined in the lower wells by manual counting or with Cyquant
ﬂuorescent dye (Molecular Probes, Eugene, Oregon, United States) in
a Cytoﬂuor Multi-Well Plate Reader Series 4000 (Applied Biosystems,
Foster City, United States).
NK cell transfer into CCR5
 / mice. Naı ¨ve splenocytes from C57BL/
6 x129 mice were collected as described above. Spleen cells were
depleted of CD4
þ T cells, CD8
þ T cells, and B cells by magnetic
sorting. The remaining cells were positively selected using a DX5
mAb (BD Pharmingen) and MACS (Miltenyi Biotec). DX5
  cells were
isolated by negative selection from naı ¨ve splenocytes using anti-DX5
mAb and a magnetic column. Less than 1% of the DX5
  fraction
stained positive for NK1.1
þ as determined by FACS analysis.
Statistical analysis. Results of experimental studies are reported as
mean 6 standard deviation. Differences were analyzed using
Student’s t-test. A p-value less than 0.05 was regarded as signiﬁcant.
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